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Abstract
Background: Squamous cell carcinoma of the head and neck can present as a cervical metastasis from an
unknown primary site. Recently, transoral robotic surgery (TORS) and transoral laser microsurgery (TLM) have been
incorporated in the workup of unknown primary tumors.
Methods: We searched MEDLINE, EMBASE, Cochrane, and CINAHL from inception to June 2015 for all English-
language studies that utilized TORS, TLM, or lingual tonsillectomy in the approach to an unknown primary.
Results: Of 217 identified studies, eight were reviewed. TORS/TLM identified the primary tumor in 111/139 (80 %)
patients overall, and 36/54 (67 %) patients with no remarkable findings following physical exam, radiologic imaging,
and panendoscopy with directed biopsies. Lingual tonsillectomy identified the primary tumor in 18/25 (72 %)
patients with no findings. Hemorrhage (5 %) was the most common perioperative complication.
Conclusion: Lingual tonsillectomy using new approaches such as TORS/TLM may improve the identification of
occult primary tumors.
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Background
Cervical metastases from an unknown primary tumor
site account for 2 to 5 % of all squamous cell carcinoma
of the head and neck [1, 2]. Identification of the primary
site may have an impact on disease control and survival,
in addition to potentially minimizing treatment-related
toxicity from large volume head and neck mucosal
irradiation [2–7].
The standard workup of an unknown primary consists
of a history, physical examination with flexible endoscopy,
and diagnostic imaging such as computed tomography
(CT) and/or magnetic resonance imaging (MRI).
Positron-emission tomography (PET), alone or fused with
CT images (PET-CT), may improve the diagnostic sensi-
tivity when traditional imaging modalities fail to localize a
primary tumor [1, 4, 8, 9]. When the primary tumor re-
mains elusive despite these modalities, examination under
anesthesia with panendoscopy and directed biopsies of the
nasopharynx, hypopharynx, and oropharynx has been the
traditional approach. The definition of an unknown pri-
mary is neither absolute nor static; a primary tumor site
identified by any diagnostic modality is, by definition, no
longer an unknown primary. Despite this extensive
workup, however, over 50 % of primary tumors remain
undiscovered [1, 3, 10, 11].
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In the absence of a visible or palpable lesion, a palatine
tonsillectomy may improve the diagnostic yield of an occult
primary tumor compared to deep tonsil biopsies [12–14],
as many occult primaries maybe hidden deep in tonsillar
crypts. [12] Given that 80–90 % of occult primary tumors
are eventually localized in the palatine tonsil and tongue
base, palatine and lingual tonsillectomies have been recog-
nized as important additions to the diagnostic workup of
an unknown primary [1, 5, 10].
Recently, Transoral Laser Microsurgery (TLM) and
Transoral Robotic Surgery (TORS) have emerged as ef-
fective modalities to aid in the identification and treat-
ment of an unknown primary tumor. These techniques
provide enhanced visualization and maneuverability,
allowing for a complete resection of the entire tongue
base mucosa and lingual tonsils, a procedure which is
challenging to perform using traditional instrumentation
and visualization [15, 16]. Recent case series of occult
primary tumors have reported high rates of detection
ranging from 86 to 94 % using TLM [16, 17], and 72 to
90 % using TORS [15, 18, 19]. However, these studies
contain small, heterogeneous patient populations with
variable preoperative investigations and findings, and
thus cannot be directly compared.
The present study aims to conduct a systematic review
of the literature to determine the incremental benefit of
lingual tonsillectomy using TORS/TLM in localizing the
primary tumor site of regionally metastatic head and
neck squamous cell carcinoma of unknown origin.
Methods
Search strategy
A systematic review of published reports on TORS or
TLM for the workup of CUP was performed. MEDLINE,
EMBASE, Cochrane Central Register, and CINAHL were
searched from inception to June 2015 for all relevant
English-language studies. Medical Subject Headings and
keywords specifying histopathology (e.g. squamous cell
carcinoma), location (e.g. head and neck, cervical metas-
tases), unknown primary, and diagnostic approach (e.g.
TORS, TLM, or lingual tonsillectomy) were used to
identify studies. Bibliographies of all included studies
were also searched for relevant articles.
Selection criteria
Two reviewers (T.F. & A.F.) independently screened all
identified studies by title and abstract for further full text
review, and then independently reviewed these studies
for eligibility (Fig. 1). Studies were included if they used
TORS, TLM, or lingual tonsillectomy via TORS/TLM in
the diagnostic approach to head and neck squamous cell
carcinoma of unknown primary origin. Non-English and
non-original studies (i.e. reviews) were excluded. When
multiple studies were published by a single institution,
only the most recent study was included to avoid inclu-
sion of the same patients more than once in the review.
Disagreements were resolved by consensus.
Data extraction & statistical analysis
Data were extracted in duplicate by two reviewers (T.F. &
A.F.). The primary outcome was the identification rate of
an unknown primary site using TORS, TLM, or lingual
tonsillectomy performed using TORS/TLM. Information
on study design, patient and tumor characteristics, diagnos-
tic workup, margin status, and perioperative complications
was also extracted. Subgroup analysis of identification rates
were performed based on the presence or absence of posi-
tive findings on preoperative investigations including [1]:
physical examination (PE) [2], diagnostic imaging (DI) con-
sisting of computed tomography or magnetic resonance
imaging (CT or MRI) [3], positron emission tomography-
computed tomography (PET-CT) [4], a combination of PE/
DI/PET-CT, and [5] examination under anesthesia (EUA)
with directed biopsies of the nasopharynx, hypopharynx,
tonsil, and base of tongue. Data were aggregated using
Microsoft Excel 2010 (Microsoft Corp., Redmond,
Washington), and all statistical analyses were conducted
using SPSS version 21.0 (SPSS Inc., Chicago, Illinois).
Results
Study selection
The literature search identified a total of 217 articles
(Fig. 1). Excluded studies included those that did not use
TORS, TLM, or lingual tonsillectomy (64), duplicates
(48), non-original studies (31), non-English studies (26),
studies of non-head and neck neoplasms (17), studies
without mention of unknown primary (11), and those
reporting on non-SCC histopathology (6). Of the 14
remaining studies, three were follow-up studies [20–22]
from the same institution, one study [23] was excluded
due to insufficient data, one study [24] did not use
TORS or TLM in the diagnostic workup, and one study
[25] was a review paper. Inter-rater agreement for study
inclusion was excellent (κ = 0.92).
Eight studies containing a total of 139 patients met the
final inclusion criteria [15–19, 26–28]. Of these eight
studies, six studies [15, 18, 19, 26–28] reported out-
comes for 85 patients undergoing TORS for workup of
an unknown primary, and two studies [16, 17] reported
outcomes for 54 patients undergoing TLM.
Study characteristics
Characteristics of the eight included studies are summa-
rized in Table 1. Included studies were case series or
case reports published between 2011 and 2014. All were
single-institution studies aside from one study [15]
which pooled data from six institutions.
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Patient characteristics are summarized in Table 2. The
mean age of patients undergoing TORS or TLM was
57.3 years (standard deviation [SD] 2.1, range 44–78 years).
Patients were predominantly male (88 %), and the major-
ity (82 %) of the 65 patients with a reported p16 status
were positive [15, 18, 19, 26, 27]. Of the 94 patients with
known nodal status, 19 (20 %) were N1, 62 (66 %) were
N2, and 13 (14 %) were N3. The mean diameter of identi-
fied primary tumors was 1.15 cm (SD 0.79 cm, range 0.2
to 3.0 cm). Of 71 patients with known margin status, 44
(62 %) had negative margins [15, 18, 26, 27].
Diagnostic workup of unknown primary
The diagnostic workup for an unknown primary was
highly variable between institutions as shown in Table 3.
PE findings were suspicious for a primary tumor in 24 of
135 (18 %) patients. Nine of 89 (10 %) patients had sus-
picious findings on DI, and 17 of 39 (44 %) patients had
findings on PET-CT scan. Of the 78 patients undergoing
a full diagnostic workup including PE/DI/PET-CT, 43
(55 %) had suspicious findings. EUA with biopsies of the
nasopharynx, hypopharynx, and oropharynx revealed re-
markable findings in 12 of 52 (23 %) patients. All 12 pa-
tients with findings on EUA received a lingual
tonsillectomy using TORS.
A total of 108 of 139 patients (78 %) underwent lingual
tonsillectomy by TORS or TLM. Of the 90 patients with
available information, 36 (40 %) had ipsilateral lingual
tonsillectomy and 54 (60 %) had bilateral lingual tonsil-
lectomy. Three studies [17, 19, 26] explicitly described
the procedure for performing lingual tonsillectomy. The
procedure was generally consistent across all three insti-
tutions and involved complete resection of the lingual
tonsil from the midline of the tongue to the lateral
pharyngeal wall, and from the circumvallate papillae to
the vallecula, using the muscular layer as the deep plane
of dissection.
A total of 70 of 103 (68 %) patients underwent palatine
tonsillectomy by TORS or TLM. Palatine tonsillectomy
was either not performed or not reported in the remain-
der of the patients (36 of 139) for the following reasons:
(i) 20 patients in one series [15] did not undergo palatine
Fig. 1 Selection of studies for systematic review
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tonsillectomy, (ii) at least ten patients had a previous
childhood tonsillectomy [18, 19, 26], and (iii) one study
[17] did not report the frequency of palatine tonsillecto-
mies in the TORS/TLM group. Among the 55 patients
undergoing palatine tonsillectomy with available infor-
mation, 24 (44 %) had ipsilateral tonsillectomy while 31
(56 %) had bilateral tonsillectomy.
Identification of unknown primary using TORS/TLM
Overall, TORS/TLM successfully localized the primary
tumor in 111 of 139 (80 %) patients, as shown in Table 4.
An occult primary was identified in 60 of 108 (56 %)
patients undergoing lingual tonsillectomy and 34 of 70
(49 %) patients undergoing palatine tonsillectomy using
TORS or TLM. One patient undergoing TORS had syn-
chronous primary tumors found in the palatine and lin-
gual tonsils [15]. The location of the primary tumor was
not specified in the remaining 18 of 111 patients with an
occult tumor found on TLM [17].
Identification rates for subgroups of patients with posi-
tive or negative findings during preoperative investiga-
tions are shown in Fig. 2 and Table 5. In some studies,
identification rates were reported for the entire cohort
and not stratified by subgroup of patients with or with-
out abnormal findings, thus limiting the extractable data.
Only one study [26] described the identification rate in
patients with positive physical exam findings. The occult
primary was eventually localized in this patient (100 %)
with suspicious findings on PE. In contrast, the identifi-
cation rate was 86 % (75 of 87) among patients without
exam findings [16–19, 27]. The primary tumor was also
identified in 1 of 1 (100 %) patient with suspicious find-
ings on DI [26], and 43 of 50 (86 %) patients without DI
findings [16, 18, 19]. A primary tumor was identified in six
of six (100 %) patients with remarkable findings on PET-
CT [19, 26, 27], and five of six (83 %) patients without
PET-CT findings [19]. TORS/TLM localized the primary
tumor site in 34 of 43 (79 %) patients with remarkable find-
ings on either PE, DI, or PET-CT [15, 18, 19, 26, 27], and
25 of 35 (71 %) patients without findings on these investiga-
tions [15, 18, 19]. In addition, a primary tumor was identi-
fied in 11 of 12 (92 %) patients with findings on EUA with
directed biopsies [18, 27], but only 36 of 54 (67 %) patients
without EUA findings [15, 17–19, 26]. Although a total of
34 palatine tonsil primaries were identified, the location
was specified in only 13 cases [18]. Of these 13 cases, 11
(85 %) were identified in the ipsilateral tonsil, and 2 (15 %)
were found in the contralateral tonsil.
Identification of unknown primary using lingual
tonsillectomy
Similarly, identification rates were recorded for a subgroup
of patients who underwent lingual tonsillectomy performed
using TORS or TLM (Fig. 3 and Table 6). A primary tumor
site was localized in 1 of 1 (100 %) patient with suspicious
PE findings [26], and 38 of 62 (61 %) of patients without
suspicious findings [16–19, 27]. The primary tumor was
also identified in the same 1 of 1 (100 %) patient who also
had findings on DI [26], and 24 of 42 (57 %) patients with-
out findings on DI [16, 18, 19]. Lingual tonsillectomy iden-
tified the primary tumor in six of six (100 %) patients with
remarkable findings on PET-CT [19, 26, 27], and five of six
Table 2 Characteristics of patients from included studies
Characteristic No. Pts (%) (N = 139)
Age, mean (SD) 57.3 (2.1)
Sex
Female 16 (12 %)
Male 119 (88 %)
na 4
HPV
+ 53 (82 %)
- 12 (18 %)
na 74
Nodal status
N1 19 (20 %)
N2 62 (66 %)
N3 13 (14 %)
na 45
Size, mean cm (SD) 1.15 (79 %)
Negative Margins 44 (62 %)
Table 1 Summary of studies included in systematic review
Authors Year Institution No. Pts (N = 139)
Abuzeid et al. [26] 2011 University of Michigan 1
Blanco et al. [28] 2013 Johns Hopkins School of
Medicine
4
Durmus et al. [18] 2013 Ohio State University
Wexner Medical Center
22
Karni et al. [16] 2011 Washington University
School of Medicine
18
Mehta et al. [19] 2013 University of Pittsburgh
Medical Center
10
Mourad et al. [27] 2013 Albert Einstein College of
Medicine
1
Nagel et al. [17] 2014 Mayo Clinic Arizona 36
Patel et al. [15] 2013 University of Washington
Medical Center, University
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(83 %) without PET-CT findings [19]. Of the 31 patients
with suspicious findings on either PE, DI, or PET-CT, 19
(61 %) were successfully identified [15, 19, 26, 27], while
13 of 22 (59 %) patients without findings were identified
[15, 19]. A primary tumor was identified in 1 of 1 (100 %)
patient with positive findings on EUA with biopsy [27],
and 18 of 25 (72 %) patients without findings on
EUA [17, 19, 26]. Although a total of 60 primaries
were identified in the lingual tonsils, the location was
specified for only 49 patients [15, 17–19, 26, 27]. Of
these 49 tumors, 46 (94 %) were identified in the ipsi-
lateral base of tongue and 3 (6 %) were found in the
contralateral base of tongue.
Adverse events for TORS/TLM
Table 7 shows the adverse events reported in studies of
TORS or TLM. In total, six studies [15, 17–19, 26, 27]
reported overall perioperative complication rates for
117 patients and all eight studies [15–19, 26–28] re-
ported perioperative mortality rates for 139 patients.
Additionally, four studies [15, 17, 19, 28] reported
hemorrhage rates for 97 patients, one study [18] re-
ported tracheostomy rates for 22 patients, three studies
[18, 19, 28] reported gastrostomy rates for 36 patients,
and five studies [17–19, 26, 28] commented on return
to diet for 73 patients.
The most common complication was hemorrhage in 5
of 97 (5 %) patients, of which three (3 %) required return
to the operating room for hemostasis. None (0 %) of the
22 patients with available outcomes required tracheos-
tomy, and only 1 of 36 (3 %) patients required a gastros-
tomy tube. In this single patient, the requirement for a
permanent gastrostomy tube was due to adjuvant che-
moradiation and heavy tobacco use in the post-operative
period [19]. Furthermore, only 1 of 73 (1 %) patients did
not tolerate return to diet within 24 h post-operatively.
Other perioperative complications such as tongue swell-
ing [15] occurred in 1 of 87 (1 %) patients. There were
no perioperative deaths resulting from TORS or TLM.
Discussion
Localization of the primary tumor in patients with cer-
vical metastasis of unknown origin remains a challenging
yet important goal. When available diagnostic modalities
fail to detect a primary tumor, treatment typically con-
sists of large volume radiation to the neck as well as po-
tential primary mucosal sites with or without
chemotherapy, or neck dissection with or without adju-
vant chemoradiation [2–7]. Head and neck irradiation
may be associated with dysphagia, xerostomia, mucosal
atrophy, and osteoradionecrosis of the jaw [11, 29, 30].
Identification of the primary tumor site may mitigate
Table 3 Diagnostic workup and proportion of patients with suspicious findings (n = 139)
Investigation Proportion of patients with suspicious findings Proportion of patients without suspicious findings No. Patients with Missing Data
Physical Exam 24/135 (18 %) 111/135 (82 %) 4
DI (CT/MRI) 9/89 (10 %) 80/89 (90 %) 41
PET-CT 17/39 (44 %) 22/39 (56 %) 100
PE/DI/PET-CT 43/78 (55 %) 35/78 (45 %) 61
EUA with biopsy 12/52 (23 %) 40/52 (77 %) 87
Abbreviations: DI diagnostic imaging, CT computed tomography, MRI magnetic resonance imaging, PE physical examination, PET positron emission tomography,
EUA panendoscopic examination under anesthesia
Table 4 Overall identification rate of unknown primary with TORS/TLM
Author Method Proportion identified
with TORS/TLM
Proportion identified with lingual
tonsillectomy using TORS/TLM
Proportion identified with palatine
tonsillectomy using TORS/TLM
Abuzeid et al. [26] TORS 1/1 (100 %) 1/1 (100 %) 0/0 (0 %)a
Blanco et al. [28] TORS 1/4 (25 %) 0/4 (0 %) 1/4 (25 %)
Durmus et al. [18] TORS 17/22 (77 %) 4/14 (29 %) 13/17 (76 %)
Karni et al. [16] TLM 17/18 (94 %) 11/18 (61 %) 6/18 (33 %)
Mehta et al. [19] TORS 9/10 (90 %) 9/10 (90 %) 0/3 (0 %)b
Mourad et al. [27] TORS 1/1 (100 %) 1/1 (100 %) 0/1 (0 %)
Nagel et al. [17] TLM 31/36 (86 %) 13/19 (68 %) -
Patel et al. [15] TORS 34/47 (72 %) 21/41 (51 %) 14/27 (52 %)c
Total TORS/TLM 111/139 (80 %) 60/108 (56 %) 34/70 (49 %)
aPatient had childhood tonsillectomy
bSeven of ten patients had childhood tonsillectomy
cOne patient had synchronous lingual/palatine tonsil tumors
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these risks by minimizing radiotherapy volumes and also
allowing for more directed radiation, potentially sparing
the pharyngeal constrictors, salivary glands, and man-
dible. Furthermore, depending on the margin status and
pathological features of the primary tumor identified
(and resected) by any of these approaches, one may elect
to avoid radiotherapy to mucosal surfaces and manage
the neck disease in isolation. The implications of this
strategy warrant further study.
The goal of this systematic review was to determine
the effectiveness of TORS and TLM in localizing an oc-
cult primary tumor and to elucidate the role of these
techniques within the traditional diagnostic paradigm.
Our findings demonstrated that TORS/TLM can in-
crease the detection of occult primary tumors at all
stages of the diagnostic workup. We also aimed to deter-
mine the incremental benefit of using these techniques
by analyzing the identification rate of unknown
Fig. 2 Identification of unknown primary using TORS/TLM in the presence (+) or absence (-) of other findings
Table 5 Identification rate of TORS/TLM in the presence of other findings
Author Physical Exam DI (CT/MRI) PET/CT PE/DI/PET-CT EUA with biopsy
+ - + - + - + - + -
Abuzeid
et al. [26]
1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 0/0 (0 %) 1/1 (100 %)
Blanco
et al. [28]
- - - - - - - - - -
Durmus
et al. [18]
0/0 (0 %) 17/22 (77 %) 0/0 (0 %) 17/22 (77 %) - - 10/11 (91 %) 7/11 (64 %)a 10/11 (91 %) 7/11 (64 %)
Karni
et al. [16]
0/0 (0 %) 17/18 (94 %) 0/0 (0 %) 17/18 (94 %) - - - - - -
Mehta
et al. [19]
0/0 (0 %) 9/10 (90 %) 0/0 (0 %) 9/10 (90 %) 4/4 (100 %) 5/6 (83 %) 4/4 (100 %) 5/6 (83 %) 0/0 (0 %) 9/10 (90 %)
Mourad
et al. [27]
0/0 (0 %) 1/1 (100 %) - - 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %)
Nagel
et al. [17]
0/0 (0 %) 31/36 (86 %) - - - - - - - 8/14 (57 %)
Patel
et al. [15]
- - - - - - 18/26 (69 %)b 13/18 (72 %) 0/0 (0 %) 11/18 (61 %)c
Total 1/1 (100 %) 75/87 (86 %) 1/1 (100 %) 43/50 (86 %) 6/6 (100 %) 5/6 (83 %) 34/43 (79 %) 25/35 (71 %) 11/12 (92 %) 36/54 (67 %)
Abbreviations: DI diagnostic imaging, CT computed tomography, MRI magnetic resonance imaging, PE physical examination, PET positron emission tomography,
EUA panendoscopic examination under anesthesia
aNo suspicious findings on PET/CT, EUA, directed biopsies, or robotic exam
bDenominator was calculated as 47 total patients minus 18 patients without positive findings minus three patients who did not undergo radiographic imaging
before TORS
cFailed deep tongue base biopsy
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primaries in a subgroup of patients undergoing lingual
tonsillectomies. Many of the patients who are managed
with TORS and TLM undergo a palatine tonsillectomy
in addition to lingual tonsillectomy. While a palatine
tonsillectomy can be performed using more cost-
effective traditional approaches, a lingual tonsillectomy,
on the other hand, may require the superior
visualization and exposure afforded by these techniques.
In the present study, the identification rate of a primary
tumor using lingual tonsillectomy was 60/108 (56 %).
Currently, there is no standard diagnostic algorithm for
an unknown primary tumor. The typical workup includes
physical examination and diagnostic imaging consisting of
CT and/or MRI. The addition of PET and PET/CT have
resulted in improved detection rates ranging from 15 to
28 % [1, 4, 9, 11, 31] and 32 to 44 % [4, 8, 32], respectively.
Studies have also reported successful primary tumor iden-
tification using PET/CT in the presence of unremarkable
findings on physical examination, imaging, and panendo-
scopy, with identification rates ranging from 28 to 37 %
[4, 33, 34]. However, PET and PET/CT does not reliably
detect tumors smaller than 8 to 10 mm in diameter [35].
Interestingly, in our study of 111 identified primary tu-
mors, we reported an average tumor diameter of 1.15 cm,
Fig. 3 Identification of unknown primary using lingual tonsillectomy in the presence (+) or absence (-) of other findings. Abbreviations: PE,
physical examination; DI, diagnostic imaging; CT, computed tomography; MRI, magnetic resonance imaging; PET, position emitted tomography;
EUA, examination under anesthesia with directed biopsy
Table 6 Identification rate of lingual tonsillectomy in the presences of other findings
Author Physical Exam DI (CT/MRI) PET/CT PE/DI/PET-CT EUA with biopsy
+ - + - + - + - + -
Abuzeid
et al. [26]
1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 0/0 (0 %) 1/1 (100 %)
Blanco
et al. [28]
- - - - - - - - - -
Durmus
et al. [18]
0/0 (0 %) 4/14 (29 %) 0/0 (0 %) 4/14 (29 %) - - - - - -
Karni
et al. [16]
0/0 (0 %) 11/18 (61 %) 0/0 (0 %) 11/18 (61 %) - - - - - -
Mehta
et al. [19]
0/0 (0 %) 9/10 (90 %) 0/0 (0 %) 9/10 (90 %) 4/4 (100 %) 5/6 (83 %) 4/4 (100 %) 5/6 (83 %) 0/0 (0 %) 9/10 (90 %)
Mourad
et al. [27]
0/0 (0 %) 1/1 (100 %) - - 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %) 1/1 (100 %) 0/0 (0 %)
Nagel
et al. [17]
0/0 (0 %) 13/19 (68 %) - - - - - - - 8/14 (57 %)
Patel
et al. [15]





















Abbreviations: DI diagnostic imaging, CT computed tomography, MRI magnetic resonance imaging, PE physical examination, PET positron emission tomography,
EUA panendoscopic examination under anesthesia
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with 57 % of primary tumors less than 10 mm in diameter.
This finding may suggest that many of the primary tumors
in this setting are below the detection level of PET-CT im-
aging. Another limitation of PET imaging is the high false-
positive rate due to physiologic uptake in the lymphoid
tissue of Waldeyer’s ring. Recent reviews have reported
false-positive rates as high as 39 % for PET and 37 % for
PET/CT [8, 9]. These false positives may (incorrectly)
guide treating physicians to target treatment volumes
based on the areas of uptake. Histopathologic corrobor-
ation with tissue is needed prior to making treatment
decisions.
Surgical evaluation of an unknown primary involves
the use of examination under anesthesia with biopsies of
clinically and radiologically suspicious sites. Studies also
show that palatine tonsillectomy improves the detection
rate compared to tonsil biopsy in patients with demon-
strable tonsillar tissue [12, 14]. Overall, a comprehensive
diagnostic workup including physical examination, im-
aging, and panendoscopy with directed biopsies and/or
tonsillectomy reveals a primary tumor site in 19 to 53 %
of patients [1, 3–5, 10, 36]. However, in the absence of
remarkable physical examination or radiological find-
ings, detection rates are only 17 to 29 % [5, 10, 36].
In comparison, our present study demonstrates signifi-
cantly higher identification rates using TORS/TLM com-
pared to traditional diagnostic techniques, suggesting
that evaluation of the lingual tonsil with the aid of
TORS/TLM has clinical benefit in the work-up of un-
known primary tumors. In contrast to the detection
rates reported above, our review of the literature re-
vealed an identification rate of 79 % in the presence of
remarkable findings on physical examination and im-
aging, and a 92 % detection rate in the presence of re-
markable findings on panendoscopy. Most importantly,
the detection rate remained high at 71 % in the absence of
findings on physical examination and imaging (including
PET/CT), and 67 % even after failed EUA with directed bi-
opsies. This highlights a potential role for TORS/TLM in
the diagnostic algorithm of these patients as a “final step”
after failed panendoscopy.
Similar findings were noted in the subgroup of patients
undergoing lingual tonsillectomy using TORS or TLM.
The detection rate was 61 % among patients with remark-
able findings on physical examination and radiological im-
aging, and remained at 59 % among patients with
unremarkable findings. Furthermore, lingual tonsillectomy
was successful in identifying the primary tumor in 18 of 25
(72 %) patients even after failed EUA with biopsies. These
data also support the use of TORS and TLM to perform a
lingual tonsillectomy as a “last resort” when all other diag-
nostic modalities have failed to localize a primary tumor
site.
Some authors advocate for upfront lingual tonsillectomy
in the initial management of occult primary tumors rather
than awaiting the results of directed biopsies of the pharynx
[16, 17]. This approach may reduce the delay to diagnosis
and definitive treatment, and also obviate the need for a
second operation in the event of positive biopsy results.
Our data showed that lingual tonsillectomy identified the
primary tumor site in 60 of 108 patients (56 %) overall, sup-
porting a potential role for upfront lingual tonsillectomy in
select patients with unknown primary tumors. Disadvan-
tages of this approach include a longer initial operation,
and exposure to potentially unnecessary surgery and associ-
ated risks of perioperative complications. Our review of the
literature revealed that the complication rate of TORS/
TLM, while relatively low (7 %), was not zero [15, 17–19,
26]. The potential impact on quality of life (QOL) is an-
other important consideration, with a recent study demon-
strating a significant decline in multiple QOL domains
such as speech, eating, aesthetics, and social disruption up
to 12 months post-treatment with TORS [20]. Further
research is needed to evaluate long-term QOL outcomes
Table 7 Adverse events following TORS/TLM
Author Hemorrhage Tracheostomy Gastrostomy No Return to diet Other Deaths Total Complications
Abuzeid et al. [26] - - - 0/1 (0 %) - 0/1 (0 %) 0/1 (0 %)
Blanco et al. [28] 0/4 (0 %) - 0/4 (0 %) 0/4 (0 %) 0/4 (0 %)a 0/4 (0 %) -
Durmus et al. [18] 0/22 (0 %) 0/22 (0 %) 0/22 (0 %) - 0/22 (0 %) 0/22 (0 %)
Karni et al. [16] - - - - - 0/18 (0 %) -
Mehta et al. [19] 0/10 (0 %) - 1/10 (10 %)b 1/10 (10 %)b - 0/10 (0 %) 2/10 (20 %)
Mourad et al. [27] - - - - - 0/1 (0 %) 0/1 (%)
Nagel et al. [17] 1/36 (3 %)c - - 0/36 (0 %) 0/36 (0 %) 0/36 (0 %) 1/36 (3 %)
Patel et al. [15] 4/47 (9 %)d - - - 1/47 (2 %)e 0/47 (0 %) 5/47 (11 %)
Total 5/97 (5 %) 0/22 (0 %) 1/36 (3 %) 1/73 (1 %) 1/87 (1 %) 0/139 (0 %) 8/117 (7 %)
aNo patients developed esophageal strictures
bPatient was a heavy smoker (60 packs/year) with an identified HPV-negative 2.0 cm submucosal tongue base tumor
cPostoperative tonsil bleed requiring return to OR
dTwo patients required return to OR
eOne patient had tongue swelling requiring one additional day of observation before discharge
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following TORS/TLM and investigate the role of lingual
tonsillectomy in the initial work up of occult primary
tumors.
Our findings corroborate previous studies that suggest
that subsites of the oropharynx such as the palatine ton-
sil and tongue base are the most common sites of occult
primary tumors [5, 10, 12, 15]. This is likely due to the
fact that small primary tumors can be hidden in areas
that are difficult to visualize such as the palatine and lin-
gual tonsillar crypts. The justification for performing a
palatine tonsillectomy for detection of a hidden primary
tonsillar cancer can similarly be applied to the tongue
base, where a lingual tonsillectomy is necessary to iden-
tify small hidden primaries.
The issue of “bilaterality” or contralateral tumor resec-
tion is one that warrants discussion. In our study, we re-
port a contralateral primary tumor in the tongue base in
6 % of the contralateral tongue base and 15 % in the
contralateral tonsil. This proportion is comparable to pre-
vious reports which have found bilateral or contralateral
palatine tonsil disease in 10 to 23 % of identified primary
tumors [13, 37, 38]. However, it remains unclear whether
these represent multiple primary tumors or multicentric
disease that has been described in human papillomavirus
(HPV) mediated oropharyngeal carcinoma compared to
isolated contralateral disease [24, 39, 40]. Regardless, these
findings support the use of bilateral palatine and/or
lingual tonsillectomy as part of a comprehensive diagnos-
tic workup or staged resection of the contralateral palatine
tonsil and lingual tonsil in the event that no primary is
found on the ipsilateral side. However, clinical judgment is
required to weigh potential benefits and risks, and deter-
mine the optimal approach for each individual patient
[13–16].
This study is limited by the small sample size of included
studies, particularly for the subgroup of patients receiving
lingual tonsillectomy, as well as the heterogeneity between
diagnostic workup performed at different institutions. This
is not surprising given the relatively recent advent of this
expanded surgical paradigm in the investigation of head
and neck carcinoma of unknown primary. Our study high-
lights the need for a standardized diagnostic and treatment
approach to unknown primary tumors that also considers
emerging transoral surgical procedures such as TORS and
TLM. Inter-institutional and inter-surgeon variation in the
technique used to perform lingual tonsillectomy could have
also affected our findings, particularly given that only three
studies [17, 19, 26] provided a general description of this
procedure. More frequent and detailed reporting on surgi-
cal technique is needed to further investigate the impact of
inter-institutional variation on identification rates. Another
potential limitation is publication bias, as institutions with
more favorable results may be more likely to publish their
findings, particularly for the newer TORS/TLM techniques.
Despite these limitations, this is the first systematic review
to comprehensively evaluate the use of TORS/TLM and
lingual tonsillectomy specifically for the identification of
primary head and neck squamous cell carcinoma with an
unknown primary site. By pooling data from multiple insti-
tutions with varying methods of preoperative assessment,
we were able to gather a relatively large sample size and
minimize single-surgeon and single-institution biases. Fu-
ture prospective studies with more patients and standard-
ized diagnostic and treatment protocols are needed to
further investigate the usefulness and cost-effectiveness of
these newer transoral surgical techniques, and corroborate
the encouraging results presented in this study.
Conclusion
This systematic review supports the use of TORS and TLM
to aid in the identification of a primary head and neck squa-
mous cell carcinoma of unknown origin, with superior de-
tection rates compared to the traditional diagnostic workup.
We also demonstrate that the addition of formal lingual ton-
sillectomy using TORS/TLM is a safe and effective option
that can increase the yield of localizing an occult primary
tumor. Identification of the primary tumor using minimally-
invasive transoral techniques reduces treatment-induced
morbidity and permits directed management, thereby po-
tentially improving survival and functional outcomes.
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